Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $...(Decatur $75000 Illinois ...),Health
Navigation Links
Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million
Date:5/14/2008
Decatur $75,000
Illinois
DePaul University (facilities capital) Chicago $1,000,000
IFF Loan Fund and Advisory Services
(PRI and growth capital) Chicago $3,000,000
Indiana
Middle Way House Inc. (facilities capital) Bloomington $400,000
Massachusetts
Capital Link Inc. (PRI and growth capital) Boston $2,500,000
Health Care Without Harm (program support) Jamaica Plain $600,000
The Nonprofit Quarterly (program support) Boston $130,000
Wheelock College (facilities capital) Boston $800,000
Maine
The Chewonki Foundation (facilities capital) Wiscasset $850,000
Michigan
Black Family Development (Detroit Program) Detroit $100,000
Children's Aid Society (Detroit Program) Detroit $82,000
College for Creative Studies (Detroit Program) Detroit $260,000
Detroit Community Initiative Inc.
(Detroit Program) Detroit $145,000
Detroit Economic Growth Association
(Detroit Program) Detroit $750,000
Detroit Educational Television Foundation
(facilities capital) Wixom $1,250,000
Henry Ford Health System (Detroit Program) Detroit $250,000
New Center Council Inc. (Detroit Program) Detroit $150,000
The Corner Health Center (facilities capital) Ypsilanti $250,000
University of Detroit Mercy (facilities capital) Detroit $2,000,000
Minnesota
First Children's Finance
(PRI and growth capital) Minneapolis $2,000,000
Missouri
YMCA of Greater St. Louis (facilities capital) St. Louis $530,000
New Je
'/>"/>
| SOURCE The Kresge Foundation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Fox Chase Cancer Centers Ning Wong receives ASCO Cancer Foundation Career Development Award
2. Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke
3. Cystic Fibrosis Foundation President Rings Bell to Close New York Stock Exchange
4. Gladney Center for Adoption Receives Whole Health Grant from Aetna Foundation
5. Chrysler LLC Vice Chairman and President Jim Press and His Wife Suwichada Serve as Honorary Co-Chairs of Annual Juvenile Diabetes Research Foundation Promise Ball
6. The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity
7. Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry
8. Brainfood Awarded $25,000 Grant from General Mills Foundation through DC Mayor Fentys New Health Communities Program
9. Patti LaBelle Wows Crowd at 5th Annual Lupus Foundation of America Awards Gala
10. The 29th Annual DC101 Chili Cook-Off Benefiting the National Kidney Foundation
11. The Lucian Leape Institute at the National Patient Safety Foundation Announces the Appointment of Two New Members
Post Your Comments:
(Date:11/21/2008)... LAKES, N.J., Nov. 21 To...edical intervention in treating 88 percent of pati... of Americans treated for a chronic condition acco...ng and 75 percent of all medical costs. A proprie... by Medco Health Solutions, Inc. (NYSE: MHS ) si...
(Date:11/21/2008)...nts in mice find running increases production of n...althDay News) -- In experiments in mice, exercise ...f brain stem cells usually seen with aging, Taiwan...ration of the brain,s ability to stave off aging a...a neurochemical that is essential for the producti...
(Date:11/21/2008)..., Nov. 21 /PRNewswire/ -- For the second year i..., McCann Healthcare Worldwide,s agency network wo...rk at the 22nd annual international RX Club Show. ...y offices won a total of 59 RX Club Awards of Exce...ng McCann Healthcare Worldwide agencies include Ca...
(Date:11/21/2008)...Nov. 21 Innerscope Research(TM), a...ializing in Emotional Response Measurement,annou... will strengthen the,company,s research and devel...es. , The three appointments, who deliver a...y Gill as Chief Financial Officer and Vice Preside...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Exercise Keeps the Brain Young 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2[0] New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes[0] Exercise Keeps the Brain Young[0] McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008[0] Innerscope Research Strengthens Management Team With Three Executive Appointments
...orn to women with high levels of lead in their bon... babies exposed to lead from sources like old pain...the journal Pediatrics, they said this type of lea... health problem, in view of the long residence tim...
...t with medications can reduce abdominal fat in peo...rsity of Texas have been looking into the effect t...2 diabetes.// They studied 10 people with the cond... After this time body weight had, on the whole, in...
...ect people who are at high risk of suffering a str...is cheap enough to be used by opticians and GPs to...cell death due to bleeding from damaged blood vess...e in high-risk patients are available, so doctors ...
...tective substances, produced by the body in stress... TB bacteria, researchers in the UK report. Accord...ature Medicine,// these heat-shock proteins, which...cells survive stressful times and bolster the immu...
Other Medicine News:(Date:11/20/2008)..., , , , PHILADELPHIA, Nov. 20 /PRNe... today announced that the United States Food and D...val for PROMACTA(R) (eltrombopag) for the treatmen...une (idiopathic) thrombocytopenic purpura (ITP) wh...oids, immunoglobulins or splenectomy. The approval...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire-F...hat the Anti-infective Drugs Advisory Committee of...voted 17 to 2 against the,approval of intravenous...for,the treatment of patients with complicated sk...ing those caused by methicillin-resistant Staphylo...
(Date:11/20/2008)...MERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ ...company will present results from the Phase 1B,cl...nced metastatic breast,cancer, BZL101, at the Soc...l,Conference in Atlanta, Georgia. The Company,s ...bstract and will be presented as a part of the Bes...
(Date:11/20/2008)...AMBRIDGE, Mass., Nov. 20 Radius He... an additional $15 million to its second instituti...vestment to $82.5 million and the total amount rai...n. All existing institutional investors participat...ic Fund and including MPM Capital, The Wellcome Tr...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 1Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 3Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 4Most Off Label Cancer Drug Use for Palliative Care 27727 1Most Off Label Cancer Drug Use for Palliative Care 27727 2The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U S 27723 1The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U S 27723 2Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 27719 1Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 27719 2[0] FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder[0] Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome[0] Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology[0] Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
...ique suggests how lithium works as a,therapeutic ,...CLA have shown,that lithium, long the standard tre...of gray matter in the brains of patients with,the ...issue of the journal,Biological Psychiatry and is ...clinical neuropsychologist and assistant,professor...
... Oncology Portfolio, SOUTH SAN FRANCISCO, Calif., ...rmaceuticals, Inc. today,announced the presentatio...mall molecule inhibitors of select kinases as,pote...d other,disorders. Rigel scientists will give the ...th to 18th (see list below) at the,upcoming meetin...
Other Medicine Technology:UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 2UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 3Rigel to Present New Research Programs at AACR Meeting 2Rigel to Present New Research Programs at AACR Meeting 3Rigel to Present New Research Programs at AACR Meeting 4Rigel to Present New Research Programs at AACR Meeting 5It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband.
A rapid rise in intracranial pressure requires early recognition, intervention and continuous monitoring. Ventrix utilizes state-of-the-art fiberoptic technology that gets to the source of pressure.
The Codman ICP Monitoring System provides highly accurate measurements of intracranial pressure at the source-subdural, parenchymal or intraventricular levels. The information is relayed electronical
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |